tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Zealand Pharma initiated with an Outperform at BNP Paribas Exane

BNP Paribas Exane analyst Kirsty Ross-Stewart initiated coverage of Zealand Pharma (ZLDPF) with an Outperform rating and DKK 905 price target While timing “may be debated,” the attractive risk-reward is “difficult to ignore” at current levels, the analyst tells investors.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1